PDB2 A PHARMACOECONOMIC EVALUATION FOR DIABETES TYPE 2 (DM 2) PATIENTS WITH INHIBITORS OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ANDTHIAZOLIDINEDIONES (TZD) AS ADD-ONTHERAPY
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64950-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)64950-9/fulltext
Title :
PDB2 A PHARMACOECONOMIC EVALUATION FOR DIABETES TYPE 2 (DM 2) PATIENTS WITH INHIBITORS OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) ANDTHIAZOLIDINEDIONES (TZD) AS ADD-ONTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64950-9&doi=10.1016/S1098-3015(10)64950-9
First page :
Section Title :
Open access? :
No
Section Order :
109